Crown Lifters (CROWN)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• High promoter holding of 69.56% aligns owner and minority interests.
• ROCE of 18.88% indicates decent return on capital employed despite the downturn.
• Debt/Equity of 0.67 is moderate and not dangerously over-leveraged.
• Latest quarter remains profitable with ₹9 Cr sales and ₹2 Cr net profit.
• P/E of 13.76 is not demanding if earnings can stabilise.

Concerns

• Profit growth of -36.74% against sales growth of -2.30% shows severe margin compression.
• Piotroski F-Score of 3/9 signals weak financial health and limited improvement signals.
• Zero dividend yield provides no income cushion for shareholders.
• P/B of 2.12 means paying more than double book value, leaving little asset-based margin of safety.

AI Analysis

At ₹138.42, Crown Lifters is a small, ₹136 crore market-cap business. A P/E of 13.76 looks reasonable, but Graham taught me to treat a low multiple as an invitation to ask why, not a shortcut to value. The why is visible: sales fell 2.30% while profits crashed 36.74%. That type of operating leverage is common in a cyclical industrial-products company with fixed costs and little pricing power. I don't see a durable moat in these numbers. Book value is ₹65.21, so at 2.12 times book I am paying double for assets; this is not an asset play. ROCE of 18.88% is respectable, and debt/equity of 0.67 is manageable, but with no dividend yield the investor depends entirely on future earnings improvement. Promoter holding of 69.56% is a genuine positive—owners remain aligned—but high ownership cannot substitute for deteriorating fundamentals. The Piotroski F-score of 3/9 is a red flag; it suggests weakening financial health across margins, leverage or efficiency. The latest quarter's ₹9 crore sales and ₹2 crore profit at least show a positive, not loss-making, operation. Still, one good quarter does not make a trend. This is the kind of cyclical that must be bought with a margin of safety and monitored closely. If the cycle turns and demand returns, the 18.88% ROCE could translate into solid earnings at this price. If it doesn't, the current P/E may become optically cheaper as estimates fall. I would not buy without evidence of stabilisation; I would wait for sales growth to turn positive and profit decline to narrow.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer